home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

5th Annual Conference in Japan for Asian New Drug Development

 
  November 24, 2010  
     
 
Tower Hall Funabori , Tokyo, Japan
May 10 2011 8:00AM - May 11 2011 4:00PM


The fourth annual conference for Asian new drug development was held in Tokyo in April, 2010. Several issues about Asian development were discussed
intensively from the sponsor’s and the regulatory reviewer’s point of view.

For the fifth conference, the program committee has been joined by colleagues from East Asian countries – China, the Republic of Korea,
Chinese Taipei, and Japan – who are actively involved in drug development in Asia. Nowadays, the practical organizations for Asian collaboration have
been set up and several fruitful outcomes have been published. The more critical topics have been selected.

Main topics are as follows:
1) Oncology
2) Pharmacogenomics
3) Safety Reporting, Pharmacovigilance
4) GCP Compliance and Inspection
Several experts in drug development from China, the Republic of Korea, Chinese Taipei, and Japan will share their experiences and discuss how we
can contribute to healthcare and the patients in Asia. We are also planning for opportunities for substantive discussion with Asian regulators including
PMDA in order to develop new drugs which contribute to public health.


Event Code:
11302

 
 
Organized by: DIA Japan
Invited Speakers: Call contact
 
Deadline for Abstracts: Call contact
 
Registration:

tel +81-3-5833-8444 • fax +81-3-5820-8448

Keiko Cambridge

keiko.cambridge@diajapan.org 

 

E-mail: keiko.cambridge@diajapan.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.